XERS
XERS
US98422E1038
Xeris Biopharma Holdings, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 291.845.000 203.070.000
43.7%
Cost of Revenue 42.569.000 36.832.000
15.6%
Gross Profit 249.276.000 166.238.000
50.0%
224.380.000 199.884.000
12.3%
Operating Income 24.896.000 -33.646.000
174.0%
Pretax Income 554.000 -57.104.000
101.0%
Net Income Common Stockholders 554.000 -54.836.000
101.0%
-- --
--
-- --
--
ende